PDE4DIP
Basic information
Region (hg38): 1:148808140-149048286
Previous symbols: [ "CMYA2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE4DIP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 14 | ||||
missense | 8 | |||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 1 | 2 | 1 | 15 | 6 |
Highest pathogenic variant AF is 0.00000657
Variants in PDE4DIP
This is a list of pathogenic ClinVar variants found in the PDE4DIP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-148931908-C-G | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
1-148953028-T-A | Benign (Sep 12, 2018) | |||
1-148953102-A-C | not provided (-) | |||
1-148953147-G-A | See cases | Pathogenic (Jun 01, 2021) | ||
1-148953206-G-A | Likely benign (Feb 01, 2023) | |||
1-148953402-A-G | Benign (May 04, 2018) | |||
1-148953512-T-G | Likely benign (Apr 01, 2023) | |||
1-148953659-C-T | Likely benign (Apr 01, 2023) | |||
1-148960636-TTTGCCGTTTCTTCC-T | Benign (Sep 12, 2018) | |||
1-148960744-GA-G | not specified | Benign (Mar 28, 2016) | ||
1-148961952-G-A | Benign (Sep 12, 2018) | |||
1-148962237-A-C | Likely benign (Mar 01, 2023) | |||
1-148962551-C-T | Likely benign (May 04, 2018) | |||
1-148962565-A-G | Likely benign (Apr 01, 2023) | |||
1-148962598-C-T | Likely benign (Nov 01, 2022) | |||
1-148962619-G-A | Likely benign (Mar 01, 2023) | |||
1-148967799-G-A | Benign (Jan 17, 2024) | |||
1-148968850-AC-A | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
1-148968883-G-A | Likely benign (Nov 01, 2022) | |||
1-148968914-C-T | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
1-148991964-T-C | Likely benign (Mar 01, 2023) | |||
1-149002894-G-A | Likely benign (Mar 01, 2023) | |||
1-149002952-C-T | See cases | Likely pathogenic (Jun 01, 2021) | ||
1-149003009-G-A | Likely benign (Feb 01, 2024) | |||
1-149005085-C-T | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE4DIP | protein_coding | protein_coding | ENST00000369356 | 44 | 240030 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.61e-37 | 0.907 | 121928 | 0 | 3820 | 125748 | 0.0153 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.40 | 1136 | 1.01e+3 | 1.12 | 0.0000525 | 14285 |
Missense in Polyphen | 365 | 366.66 | 0.99547 | 5461 | ||
Synonymous | 0.266 | 376 | 383 | 0.983 | 0.0000186 | 4083 |
Loss of Function | 3.13 | 76 | 112 | 0.680 | 0.00000603 | 1376 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00965 | 0.00965 |
Ashkenazi Jewish | 0.0101 | 0.0102 |
East Asian | 0.00152 | 0.00152 |
Finnish | 0.0471 | 0.0478 |
European (Non-Finnish) | 0.0164 | 0.0164 |
Middle Eastern | 0.00152 | 0.00152 |
South Asian | 0.0167 | 0.0166 |
Other | 0.0103 | 0.0103 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as an anchor sequestering components of the cAMP-dependent pathway to Golgi and/or centrosomes (By similarity). {ECO:0000250|UniProtKB:Q9WUJ3}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.;
Intolerance Scores
- loftool
- 0.984
- rvis_EVS
- 7.99
- rvis_percentile_EVS
- 99.95
Haploinsufficiency Scores
- pHI
- hipred
- hipred_score
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Pde4dip
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- cellular protein-containing complex assembly;regulation of Golgi organization
- Cellular component
- nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril
- Molecular function
- protein binding;enzyme binding;protein-containing complex scaffold activity